Celldex Therapeutics
CLDX
Reported
Thursday, February 27
Q4 2024 Earnings
| (USD) | Expected | Reported | Surprise $ | Surprise % |
|---|---|---|---|---|
| EPS | -0.73 | -0.71 | 0.02 | 2.74% |
| Revenue | 1.31M | 1.18M | -135K | -10.31% |
WhatIF - Earnings
EPS Beat Expectations by $0.02
Celldex Therapeutics (CLDX:NASDAQ) has never beaten EPS by this much before
There’s a first time for everything